Data Bridge Market Research analyzes that the South Asia molecular point of care testing (using NAAT) market will grow at a CAGR of 10.8% from 2021 to 2028. The other factors, such as the lack of skilled professionals and the high cost of customized molecular point of care testing (using NAAT), hamper the growth of the South Asia molecular point of care testing (using NAAT) market. On the other hand, the increased healthcare expenditure and emerging countries with developed hospitals act as an opportunity to grow the South Asia molecular point of care testing (using NAAT) market.
South Asia molecular point of care testing (using NAAT) market is expected to grow due to improving healthcare facilities and infrastructures and the adoption of end-of-care testing at the hospital, laboratories, and clinics, which can drive the market growth. The other factors anticipated to propel the development of the molecular point of care testing (using NAAT) market include the rising prevalence of infectious diseases.
Market Analysis and Insights
POCT is characterized as testing which can be done close to the patient where a medical decision can be made immediately, including the results and monitoring. POCT devices now entering clinical use are based on nucleic acid amplification technologies (NAAT), defined here as second-generation devices. These platforms generally have improved sensitivity, typically 60 to 90%, compared to first-generation POCTs, and require portable instrumentation with a footprint of approximately 30cm x 30cm. These instruments are essentially used in molecularly detecting various disorders such as HIV, HPV, and respiratory disease through NAAT technology. NAAT is Nucleic Acid Amplification Techniques that allow the identification of pathogenic organisms by detecting their DNA or RNA.
In the worldwide pandemic, attempt to synergize the sensitivity of NAATs and the ease of use of POCT assays, miniaturized NAAT-based POCT devices and assays were devised for faster screening and diagnosis of COVID-19, which also propelled the growth of the market.
Get Your Sample Today: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=south-asia-molecular-point-of-care-testing-using-naat-market
South-Asia Molecular Point of Care Testing (Using NAAT) Market Scope
South Asia molecular point of care testing (using NAAT) market is categorized into five notable segments based on the product, indication, end user, mode of testing, and distribution channel. The growth amongst these segments will help to analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
· Instruments
· Consumables and Reagents
Based on product, the South Asia molecular point of care testing (using NAAT) market is segmented into instruments, consumables and reagents.
Indication
· Sexually Transmitted Infection (STI) Testing
· Respiratory Infection Testing
· Gastrointestinal Tract Infection Testing
· Others
Based on indication, the South Asia molecular point of care testing (using NAAT) market is segmented into sexually transmitted infection (STI) testing, respiratory infection testing, gastrointestinal tract infection testing, and others.
End User
· Laboratories
· Hospitals
· Clinics
· Ambulatory Centers
· Home Care
· Assisted Living Facilities
· Others
Based on End User, the South Asia molecular point of care testing (using NAAT) market is segmented into laboratories, hospitals, clinics, ambulatory centers, home care, assisted living facilities, and others.
Mode of Testing
· Prescription-Based Testing
· OTC Testing
Based on mode of testing, the South Asia molecular point of care testing (using NAAT) market is segmented into prescription-based testing and OTC testing.
Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
Buy Now Access Full Report:- https://www.databridgemarketresearch.com/reports/south-asia-molecular-point-of-care-testing-using-naat-market
South-Asia Molecular Point of Care Testing (Using NAAT) Market Country Level Analysis
India dominates the South Asia molecular point of care testing (using NAAT) market with a CAGR of around 18.9% in terms of market share and market revenue. It will continue to flourish its dominance during the forecast period. This is due to the rising technological advancements in the products and the increasing demand for point of care testing.
South Asia molecular point of care testing (using NAAT) market report covers India, Pakistan, Bangladesh and the rest of South Asia.
South Asia molecular point of care testing (using NAAT) market is analyzed, and market size insights and trends are provided based on product, indication, end user, mode of testing, and distribution channel.
The countries covered in the nuts market report are
· India,
· Pakistan,
· Bangladesh and the rest of South Asia.
Major TOC of the South-Asia Molecular Point of Care Testing (Using NAAT) Market Report
Chapter One:
CHAPTER ONE - MARKET SEGEMENTATION
CHAPTER TWO - EXECUTIVE SUMMARY
CHAPTER THREE - PREMIUM INSIGHTS
CHAPTER FOUR - MARKET OVERVIEW
Browse The Table of Contents And List of Figures https://www.databridgemarketresearch.com/toc/?dbmr=south-asia-molecular-point-of-care-testing-using-naat-market
Competitive Landscape and South-Asia Molecular Point of Care Testing (Using NAAT) Market Share Analysis
South Asia molecular point of care testing (using NAAT) market competitive landscape provides details about the competitor. Components included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, South Asia presence, production sites and facilities, company strengths and weaknesses, product launch, regulatory guidelines, brand analysis, product approvals, product payload, application dominance, technology lifeline curve. The above data points provided are only related to the companies' focus pertaining to the South Asia molecular point of care testing (using NAAT) market.
The major players covered in the Military Truck Marketreport are
· SD Biosensor, Inc.,
· Abbott, F.Hoffmann-La Roche Ltd.,
· Danaher, Thermo Fisher Scientific Inc,
· Lucira, Meridian Bioscience,
· Quantumdx Group Ltd.,
· BD, Biomérieux Sa,
· Qiagen, Quidel Corporation,
· Bio-Rad Laboratories, Inc.,
· Randox Laboratories Ltd.,
· GenMark Diagnostics, Seegene Inc.
· Grifols S.A., Wondfo, Oxford Nanopore Diagnostic,
· PerkinElmer Inc., and Co-Diagnostic among others.
Browse Related Reports @
Asia-Pacific Teleradiology Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market opportunities and foster efficient information for your business to thrive in the Market
Contact:
Data Bridge Market Research
Tel: +1-888-3895-2818
